AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
aim immunotech股票價格上漲，該公司宣佈早期接觸項目研究ampelgen的數據分析報告已印刷出版。
AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
aim immunotech股票價格上漲，該公司宣佈早期接觸項目研究ampelgen的數據分析報告已印刷出版。
資訊熱榜
更新時間